Monoclonal antibody and hybridoma producing the same

Details for Australian Patent Application No. 2004220156 (hide)

Owner Taisho Pharmaceutical Co., Ltd.

Inventors Komurasaki, Toshi

Agent FB Rice

Pub. Number AU-B-2004220156

PCT Pub. Number WO2004/081047

Priority 2003-070864 14.03.03 JP

Filing date 15 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 19 April 2007

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/081047 Priority application(s): WO2004/081047

19 April 2007 Application Accepted

  Published as AU-B-2004220156

23 August 2007 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220163-Physiologically active polypeptide conjugate having prolonged in vivo half-life

2004220150-Multilayer structures, packages, and methods of making multilayer structures